Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$72.21
+1.11%
Mkt Cap $451.19M
Analyst Ratings
Buy
6
Hold
1
Sell
0
Price Target (24 analysts)
$126.00
Range $105.00 – $145.00
Implied Upside
+74.5%
Consensus $126.00 vs current $72.21
NASDAQ·Healthcare·Biotechnology
$72.21
+1.11%
Mkt Cap $451.19M
Buy
6
Hold
1
Sell
0
Price Target (24 analysts)
$126.00
Range $105.00 – $145.00
+74.5%
Consensus $126.00 vs current $72.21